TR201006225A1 - Double-release dexlansoprazole oral tablet compositions - Google Patents

Double-release dexlansoprazole oral tablet compositions

Info

Publication number
TR201006225A1
TR201006225A1 TR2010/06225A TR201006225A TR201006225A1 TR 201006225 A1 TR201006225 A1 TR 201006225A1 TR 2010/06225 A TR2010/06225 A TR 2010/06225A TR 201006225 A TR201006225 A TR 201006225A TR 201006225 A1 TR201006225 A1 TR 201006225A1
Authority
TR
Turkey
Prior art keywords
dexlansoprazole
release
double
oral tablet
tablet compositions
Prior art date
Application number
TR2010/06225A
Other languages
Turkish (tr)
Inventor
Çi̇fter Ümi̇t
Türkyilmaz Ali̇
Öner Levent
Terki̇nli̇ Alper
Murat Üzer İbrahi̇m
Original Assignee
Sanovel İlaç San.Ve Ti̇c.A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San.Ve Ti̇c.A.Ş. filed Critical Sanovel İlaç San.Ve Ti̇c.A.Ş.
Priority to TR2010/06225A priority Critical patent/TR201006225A1/en
Priority to EP11164758A priority patent/EP2384746A3/en
Priority to EP20110164774 priority patent/EP2384747A3/en
Priority to US13/101,292 priority patent/US8563034B2/en
Publication of TR201006225A1 publication Critical patent/TR201006225A1/en
Priority to US14/033,956 priority patent/US8753682B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Abstract

Mevcut buluş dekslansoprazol ya da onun farmasötik olarak kabul edilebilir tuzlan ya da hidratlı formlannm çift salım sağlayan oral tablet bileşımlen ve buna ilaveten tablet bileşiminin uretımı ıçın bır proses ve gastroıntestınal rahatsızlıklann tedavisinde kullanımıyla ilgilidir.The present invention relates to a process for the manufacture of dexlansoprazole or its pharmaceutically acceptable salts or hydrated forms of dual release oral tablet compositions, as well as the tablet composition, and their use in the treatment of gastrointestinal disorders.

TR2010/06225A 2010-05-05 2010-07-28 Double-release dexlansoprazole oral tablet compositions TR201006225A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
TR2010/06225A TR201006225A1 (en) 2010-07-28 2010-07-28 Double-release dexlansoprazole oral tablet compositions
EP11164758A EP2384746A3 (en) 2010-05-05 2011-05-04 Dual release oral tablet compositions of dexlansoprazole
EP20110164774 EP2384747A3 (en) 2010-05-05 2011-05-04 Oral Tablet Compositions Of Dexlansoprazole
US13/101,292 US8563034B2 (en) 2010-05-05 2011-05-05 Dual release oral tablet compositions of dexlansoprazole
US14/033,956 US8753682B2 (en) 2010-05-05 2013-09-23 Dual release oral tablet compositions of dexlansoprazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/06225A TR201006225A1 (en) 2010-07-28 2010-07-28 Double-release dexlansoprazole oral tablet compositions

Publications (1)

Publication Number Publication Date
TR201006225A1 true TR201006225A1 (en) 2012-02-21

Family

ID=43608291

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/06225A TR201006225A1 (en) 2010-05-05 2010-07-28 Double-release dexlansoprazole oral tablet compositions

Country Status (1)

Country Link
TR (1) TR201006225A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165797A1 (en) * 2005-01-12 2006-07-27 Pozen Inc. Dosage form for treating gastrointestinal disorders
EP1967184A1 (en) * 2005-12-28 2008-09-10 Takeda Pharmaceutical Company Limited Controlled release solid preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165797A1 (en) * 2005-01-12 2006-07-27 Pozen Inc. Dosage form for treating gastrointestinal disorders
EP1967184A1 (en) * 2005-12-28 2008-09-10 Takeda Pharmaceutical Company Limited Controlled release solid preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
D.C. METZ ET AL.: "Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release protom pump inhibitor therapy.", ALIMENTARY PHARMACOLOGY AND THERAPEUTICS, vol. 29, 2009, pages 928 - 937, XP002625343 *

Similar Documents

Publication Publication Date Title
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
MX338712B (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof.
EA201690107A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE
MY166789A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
IN2012DN01233A (en)
UA109868C2 (en) N -alkyltriazole compounds asr
MY164646A (en) Nicotine lozenge compositions
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
WO2010092090A3 (en) Novel salts of sitagliptin
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
MX2013001677A (en) Stable formulations of linaclotide.
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
WO2011104652A3 (en) Veterinary compositions
MX347105B (en) Pharmaceutical compositions comprising hydromorphone and naloxone.
EP2384746A3 (en) Dual release oral tablet compositions of dexlansoprazole
MX340188B (en) Manufacturing of active-free granules and tablets comprising the same.
WO2010049449A3 (en) Novel salts of sunitinib
MX2012001691A (en) Orally disintegrating compositions of linaclotide.
IN2012DN00763A (en)
EP2384745A3 (en) Modified release pharmaceutical compositions of dexlansoprazole
EP2611799A4 (en) Pharmaceutical compositions of linezolid
EP2568810A4 (en) Darunavir compositions
WO2011107921A3 (en) Modified release composition of milnacipran
EP2384747A3 (en) Oral Tablet Compositions Of Dexlansoprazole
TR201006225A1 (en) Double-release dexlansoprazole oral tablet compositions